Modulation of diabetes and dyslipidemia in diabetic insulin-resistant rats by mangiferin: Role of adiponectin and TNF-α

Anais da Academia Brasileira de Ciencias

Volumn 86, Issue 4, 2014, Pages 1935-1947

  Saleh, Samira ^a,b   El Maraghy, Nabila ^c,d   Reda, Enji ^b,c   Barakat, Waleed ^c,e  

^a CAIRO UNIVERSITY   (Egypt)

^b OCTOBER 6 UNIVERSITY   (Egypt)

^c ZAGAZIG UNIVERSITY   (Egypt)

^d FUTURE UNIVERSITY IN EGYPT   (Egypt)

^e UNIVERSITY OF TABUK   (Saudi Arabia)

Author keywords

Adipokines; Diabetes; Dyslipidemia; Insulin resistance; Mangiferin

Indexed keywords

ANIMALIA; MANGIFERA INDICA; RATTUS;

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANTIDIABETIC AGENT; MANGIFERIN; ROSIGLITAZONE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; XANTHONE DERIVATIVE;

ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; INSULIN RESISTANCE; MALE; METABOLISM; PHYSIOLOGY; RAT;

ADIPONECTIN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; RATS; STREPTOZOCIN; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA; XANTHONES;

EID: 84920964265     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/0001-3765201420140212     Document Type: Article

References (71)

1. Aguila MB and Mandarim-de-Lacerda CA. 2003. Heart and blood pressure adaptations in Wistar rats fed with different high-fat diets for 18 months. Nutrition 19: 347-352.
2. Allain CC, Poon LS, Chan CS, Richmond W and Fu PC. 1974. Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475.
3. Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, Fantozzi R, Danni O and Boccuzzi G. 2009. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med 47: 1067-1074.
4. Arulselvan P and Subramanian SP. 2007. Benefcial effects of Murraya koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic beta-cells in experimental diabetes in rats. Chem Biol Interact 165: 155-164.
5. Axelsen LN, Lademann JB, Petersen JS, Holstein-Rathlou NH, Ploug T, Prats C, Pedersen HD and Kjolbye AL. 2010. Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am J Physiol Regul Integr Comp Physiol 298: R1560-R1570.
6. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J and Feve B. 2006. Recent advances in the relationship between obesity, infammation, and insulin resistance. Eur Cytokine Netw 17: 4-12.
7. Bligh EG and Dyer WJ. 1959. A rapid method of total lipid extraction and purifcation. Can J Biochem Physiol 37: 911-917.
8. Boyle PJ. 2004. What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance? Clin Cardiol 27: IV11-IV16.
9. Brewer Jr HB. 1999. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 83: 3F-12F.
10. Chang SL, Lin JG, Chi TC, Liu IM and Cheng JT. 1999. An insulin-dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia 42: 250-255.
11. Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O and Reitman ML. 2000. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106: 1221-1228.
12. Dalpe-Scott M, Heick HM and Begin-Heick N. 1982. An improved double antibody radioimmunoassay for the determination of insulin in serum, plasma, and tissue incubation media. Can J Biochem 60: 962-966.
13. Emilien G, Maloteaux JM and Ponchon M. 1999. Pharmacological management of diabetes: recent progress and future perspective in daily drug treatment. Pharmacol Ther 81: 37-51.
14. Faust IM, Johnson PR, Stern JS and Hirsch J. 1978. Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol 235: E279-E286.
15. Festi D, Colecchia A, Sacco T, Bondi M, Roda E and Marchesini G. 2004. Hepatic steatosis in obese patients: clinical aspects and prognostic signifcance. Obes Rev 5: 27-42.
16. Flegal KM, Carroll MD, Kuczmarski RJ and Johnson CL. 1998. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22: 39-47.
17. Fossati P and Prencipe L. 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28: 2077-2080.
18. Friedewald WT, Levy RI and Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
19. Giron MD, Sevillano N, Salto R, Haidour A, Manzano M, Jimenez ML, Rueda R and Lopez-Pedrosa JM. 2009. Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: role of mangiferin. Clin Nutr 28: 565-574.
20. Guha S, Ghosal S and Chattopadhyay U. 1996. Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy 42: 443-451.
21. Guo F, Huang C, Liao X, Wang Y, He Y, Feng R, Li Y and Sun C. 2011. Benefcial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol Nutr Food Res 55: 1809-1818.
22. Harrison SA, Kadakia S, Lang KA and Schenker S. 2002. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 97: 2714-2724.
23. Hoa NK, Phan DV, Thuan ND and Ostenson CG. 2004. Insulin secretion is stimulated by ethanol extract of Anemarrhena asphodeloides in isolated islet of healthy Wistar and diabetic Goto-Kakizaki Rats. Exp Clin Endocrinol Diabetes 112: 520-525.
24. Holguin F, Rojas M and Hart CM. 2007. The peroxisome proliferator activated receptor gamma (PPARgamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and infammatory cytokines in lean and obese mice. Lung 185: 367-372.
25. Hotamisligil GS, Shargill NS and Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
26. Hotta K et al. 2000. Plasma concentrations of a novel, adipose-specifc protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
27. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC and Matsuzawa Y. 2001. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133.
28. Hung HY, Qian K, Morris-Natschke SL, Hsu CS and Lee KH. 2012. Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep 29: 580-606.
29. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M and Shimomura I. 2003. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52: 1655-1663.
30. Jouad H, Eddouks M, Lacaille-Dubois MA and Lyoussi B. 2000. Hypoglycaemic effect of spergularia purpurea in normal and streptozotocin-induced diabetic rats. J Ethnopharmacol 71: 169-177.
31. Kern PA, Ranganathan S, Li C, Wood L and Ranganathan G. 2001. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751.
32. Kersten S, Desvergne B and Wahli W. 2000. Roles of PPARs in health and disease. Nature 405: 421-424.
33. Leiro J, Arranz JA, Yanez M, Ubeira FM, Sanmartin ML and Orallo F. 2004. Expression profles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int Immunopharmacol 4: 763-778.
34. Lim S, Son KR, Song IC, Park HS, Jin CJ, Jang HC, Park KS, Kim YB and Lee HK. 2009. Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat. Obesity (Silver Spring) 17: 188-195.
35. Liu S, Wu HJ, Zhang ZQ, Chen Q, Liu B, Wu JP and Zhu L. 2011. The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. Eur J Pharmacol 650: 384-389.
36. Lonardo A, Lombardini S, Ricchi M, Scaglioni F and Loria P. 2005. Review article: hepatic steatosis and insulin resistance. Aliment Pharmacol Ther 22 (Suppl 2): 64-70.
37. Lopes-Virella MF, Stone PG and Colwell JA. 1977. Serum high density lipoprotein in diabetic patients. Diabetologia 13: 285-291.
38. Markham R, Young L and Fraser IS. 1995. An amplified ELISA for human tumour necrosis factor alpha. Eur Cytokine Netw 6: 49-54.
39. Matkowski A, Kus P, Goralska E and Wozniak D. 2013. Mangiferin - a bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev Med Chem 13: 439-455.
40. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
41. Miura T et al. 2001a. Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine 8: 85-87.
42. Miura T, Iwamoto N, Kat o M, Ichiki H, Kubo M, Komatsu Y, Ishida T, Okada M and Tanigawa K. 2001b. The suppressive effect of mangiferin with exercise on blood lipids in type 2 diabetes. Biol Pharm Bull 24: 1091-1092.
43. Moller DE and Flier JS. 1991. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med 325: 938-948.
44. Murat JC and Serfaty A. 1974. Simple enzymatic determination of polysaccharide (glycogen) content of animal tissues. Clin Chem 20: 1576-1577.
45. Muruganandan S, Srinivasan K, Gupta S, Gupta PK and Lal J. 2005. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97: 497-501.
46. Pscherer S, Heemann U and Frank H. 2010. Effect of Renin-Angiotensin system blockade on insulin resistance and infammatory parameters in patients with impaired glucose tolerance. Diabetes Care 33: 914-919.
47. Puri P et al. 2009. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50: 1827-1838.
48. Ragolia L and Begum N. 1998. Protein phosphatase-1 and insulin action. Mol Cell Biochem 182: 49-58.
49. Randle PJ, Garland PB, Hales CN and Newsholme EA. 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
50. Ratziu V et al. 2008. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 135: 100-110.
51. Reaven GM and Ho H. 1991. Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism 40: 335-337.
52. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM and Reaven GM. 2000. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49: 1390-1394.
53. Risch L et al. 2006. Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum. Clin Chim Acta 373: 121-126.
54. Ruan H, Pownall HJ and Lodish HF. 2003. Troglitazone antagonizes tumor necrosis factor-alpha-induced repro-gramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J Biol Chem 278: 28181-28192.
55. Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M and Muck-Seler D. 2009. Lipid levels in female patients with affective disorders. Psychiatry Res 168: 218-221.
56. Sanchez GM, Re L, Giuliani A, Nunez-Selles AJ, Davison GP and Leon-Fernandez OS. 2000. Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 42: 565-573.
57. Saxena A and Vikram NK. 2004. Role of selected Indian plants in management of type 2 diabetes: a review. J Altern Complement Med 10: 369-378.
58. Schaalan M, El-Abhar HS, Barakat M and El-Denshary ES. 2009. Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profle, and adipocyte hormones and their modulation by rosiglitazone and glimepiride. J Diabetes Complications 23: 199-208.
59. Seda O, Kazdova L, Krenova D and Kren V. 2002. Rosiglitazone improves insulin resistance, lipid profle and promotes adiposity in a genetic model of metabolic syndrome X. Folia Biol (Praha) 48: 237-241.
60. Sellamuthu PS, Arulselvan P, Fakurazi S and Kandasamy M. 2014. Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes. Pak J Pharm Sci 27: 161-167.
61. Sellamuthu PS, Arulselvan P, Kamalraj S, Fakurazi S and Kandasamy M. 2013a. Protective nature of mangiferin on oxidative stress and antioxidant status in tissues of streptozotocin-induced diabetic rats. ISRN Pharmacol 2013: 750109.
62. Sellamuthu PS, Arulselvan P, Muniappan BP, Fakurazi S and Kandasamy M. 2013b. Mangiferin from Salacia chinensis prevents oxidative stress and protects pancreatic beta-cells in streptozotocin-induced diabetic rats. J Med Food 16: 719-727.
63. Skurk T, Alberti-Huber C, Herder C and Hauner H. 2007. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92: 1023-1033.
64. Sorg DA and Buckner B. 1964. A Simple Method of Obtaining Venous Blood from Small Laboratory Animals. Proc Soc Exp Biol Med 115: 1131-1132.
65. Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P. 2005. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52: 313-320.
66. Trinder P. 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22: 158-161.
67. Yamauchi T et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769.
68. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH and Kim JB. 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55: 2562-2570.
69. Yoosook C, Bunyapraphatsara N, Boonyakiat Y and Kantasuk C. 2000. Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine 6: 411-419.
70. Yoshikawa M, Nishida N, Shimoda H, Takada M, Kawahara Y and Matsuda H. 2001. Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activities. Yakugaku Zasshi 121: 371-378.
71. Zhou M, Xu A, Lam KS, Tam PK, Che CM, Chan L, Lee IK, Wu D and Wang Y. 2010. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. J Hepatol 53: 1108-1116.